Perrigo Company To Acquire Elan Corporation, PLC for US$8.6 Billion, Establishing Premier Global Healthcare Company

Perrigo Company To Acquire Elan Corporation, PLC for US$8.6 Billion, Establishing Premier Global Healthcare Company

- Establishes a differentiated platform for further international expansion

- Strengthens business and financial profile with highly diversified revenue streams and enhanced cash flows

- Creates a combined entity with industry-leading revenue, adjusted EBITDA and earnings growth rates

- Immediately accretive to Perrigo's adjusted earnings per share in 2014

- Creates opportunity for substantial after-tax annual operating expense and tax savings of more than US$150 million

- Elan shareholders to receive US$6.25 in cash and 0.07636 shares of New Perrigo for each Elan share, valuing each Elan share at US$16.50 based on the closing price per Perrigo share on 26 July 2013

Jul 29, 2013

For further information: Arthur J. Shannon, Vice President, Investor Relations and Communication, (269) 686-1709, E-mail: [email protected], Bradley Joseph, Senior Manager, Investor Relations and Communication, (269) 686-3373, E-mail: [email protected]

Suggested Articles

Journey Colab launches with $3 million from Apollo Projects to develop a pipeline of psychedelic compounds through a new development model.

Forma's lead asset, an IDH1 inhibitor, cleared cancer in one-third of patients with relapsed or refractory acute myeloid leukemia.

A type of white blood cell known as a granulocyte secretes growth factors that help axons of the central nervous system regenerate, researchers found.